Abstract PR018: IMA203 TCR-T targeting PRAME demonstrates potent anti-tumor activity in patients with different types of metastatic solid tumors

Name: Work Video:
Duration: 3 min 30 s
Martin Wermke; Winfried Alsdorf; Dejka M. Araujo; Manik Chatterjee; Norbert Hilf; Tobias A.W. Holderried; Amir A. Jazaeri; Mamta Kalra; Andrea Mayer-Mokler; Regina Mendrzyk; Ali Mohamed; Sapna P. Patel; Ran Reshef; Arun Satelli; Harpreet Singh; Apostolia M. Tsimberidou; Steffen Walter; Toni Weinschenk; Cedrik M. Britten; Jason J. Luke
{'id': 'https://openalex.org/W4389241704', 'doi': 'https://doi.org/10.1158/1535-7163.targ-23-pr018', 'title': 'Abstract PR018: IMA203 TCR-T targeting PRAME demonstrates potent anti-tumor activity in patients with different types of metastatic solid tumors', 'display_name': 'Abstract PR018: IMA203 TCR-T targeting PRAME demonstrates potent anti-tumor activity in patients with different types of metastatic solid tumors', 'publication_year': 2023, 'publication_date': '2023-12-01', 'ids': {'openalex': 'https://openalex.org/W4389241704', 'doi': 'https://doi.org/10.1158/1535-7163.targ-23-pr018'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-23-pr018', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5034434819', 'display_name': 'Martin Wermke', 'orcid': 'https://orcid.org/0000-0002-4844-4087'}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Martin Wermke', 'raw_affiliation_strings': ['1TU Dresden, NCT/UCC Early Clinical Trial Unit, Dresden, Germany,'], 'affiliations': [{'raw_affiliation_string': '1TU Dresden, NCT/UCC Early Clinical Trial Unit, Dresden, Germany,', 'institution_ids': ['https://openalex.org/I78650965']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052052779', 'display_name': 'Winfried Alsdorf', 'orcid': 'https://orcid.org/0000-0002-3018-2437'}, 'institutions': [{'id': 'https://openalex.org/I159176309', 'display_name': 'Universität Hamburg', 'ror': 'https://ror.org/00g30e956', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I159176309']}, {'id': 'https://openalex.org/I4210108711', 'display_name': 'University Medical Center Hamburg-Eppendorf', 'ror': 'https://ror.org/01zgy1s35', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I159176309', 'https://openalex.org/I4210108711']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Winfried Alsdorf', 'raw_affiliation_strings': ['2University Medical Center Hamburg-Eppendorf, Hamburg, Germany,'], 'affiliations': [{'raw_affiliation_string': '2University Medical Center Hamburg-Eppendorf, Hamburg, Germany,', 'institution_ids': ['https://openalex.org/I159176309', 'https://openalex.org/I4210108711']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014340135', 'display_name': 'Dejka M. Araujo', 'orcid': 'https://orcid.org/0000-0002-1223-6542'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dejka Araujo', 'raw_affiliation_strings': ['3The University of Texas, MD Anderson Cancer Center, Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '3The University of Texas, MD Anderson Cancer Center, Houston, TX,', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080827305', 'display_name': 'Manik Chatterjee', 'orcid': 'https://orcid.org/0000-0001-7854-5543'}, 'institutions': [{'id': 'https://openalex.org/I4210126310', 'display_name': 'Universitätsklinikum Würzburg', 'ror': 'https://ror.org/03pvr2g57', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210126310']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Manik Chatterjee', 'raw_affiliation_strings': ['4University Hospital Wuerzburg, Wuerzburg, Germany,'], 'affiliations': [{'raw_affiliation_string': '4University Hospital Wuerzburg, Wuerzburg, Germany,', 'institution_ids': ['https://openalex.org/I4210126310']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073708381', 'display_name': 'Norbert Hilf', 'orcid': 'https://orcid.org/0000-0002-2618-8174'}, 'institutions': [{'id': 'https://openalex.org/I4210138096', 'display_name': 'Immatics Biotechnologies (Germany)', 'ror': 'https://ror.org/04qw0nt96', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210138096']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Norbert Hilf', 'raw_affiliation_strings': ['5Immatics Biotechnologies GmbH, Tuebingen, Germany,'], 'affiliations': [{'raw_affiliation_string': '5Immatics Biotechnologies GmbH, Tuebingen, Germany,', 'institution_ids': ['https://openalex.org/I4210138096']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031749009', 'display_name': 'Tobias A.W. Holderried', 'orcid': 'https://orcid.org/0000-0002-2474-523X'}, 'institutions': [{'id': 'https://openalex.org/I2799391451', 'display_name': 'University Hospital Bonn', 'ror': 'https://ror.org/01xnwqx93', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799391451']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Tobias A.W. Holderried', 'raw_affiliation_strings': ['6University Hospital Bonn, Bonn, Germany,'], 'affiliations': [{'raw_affiliation_string': '6University Hospital Bonn, Bonn, Germany,', 'institution_ids': ['https://openalex.org/I2799391451']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000158770', 'display_name': 'Amir A. Jazaeri', 'orcid': 'https://orcid.org/0000-0003-4335-4151'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Amir A. Jazaeri', 'raw_affiliation_strings': ['7The University of Texas, MD Anderson Cancer Center, Houston, TX, Germany,'], 'affiliations': [{'raw_affiliation_string': '7The University of Texas, MD Anderson Cancer Center, Houston, TX, Germany,', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022938948', 'display_name': 'Mamta Kalra', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Mamta Kalra', 'raw_affiliation_strings': ['8Immatics US, Inc., Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '8Immatics US, Inc., Houston, TX,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091554806', 'display_name': 'Andrea Mayer-Mokler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210138096', 'display_name': 'Immatics Biotechnologies (Germany)', 'ror': 'https://ror.org/04qw0nt96', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210138096']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Andrea Mayer-Mokler', 'raw_affiliation_strings': ['5Immatics Biotechnologies GmbH, Tuebingen, Germany,'], 'affiliations': [{'raw_affiliation_string': '5Immatics Biotechnologies GmbH, Tuebingen, Germany,', 'institution_ids': ['https://openalex.org/I4210138096']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040309049', 'display_name': 'Regina Mendrzyk', 'orcid': 'https://orcid.org/0000-0002-3290-6478'}, 'institutions': [{'id': 'https://openalex.org/I4210138096', 'display_name': 'Immatics Biotechnologies (Germany)', 'ror': 'https://ror.org/04qw0nt96', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210138096']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Regina Mendrzyk', 'raw_affiliation_strings': ['5Immatics Biotechnologies GmbH, Tuebingen, Germany,'], 'affiliations': [{'raw_affiliation_string': '5Immatics Biotechnologies GmbH, Tuebingen, Germany,', 'institution_ids': ['https://openalex.org/I4210138096']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108098869', 'display_name': 'Ali Mohamed', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ali Mohamed', 'raw_affiliation_strings': ['8Immatics US, Inc., Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '8Immatics US, Inc., Houston, TX,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035218748', 'display_name': 'Sapna P. Patel', 'orcid': 'https://orcid.org/0000-0003-1339-1517'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sapna P. Patel', 'raw_affiliation_strings': ['3The University of Texas, MD Anderson Cancer Center, Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '3The University of Texas, MD Anderson Cancer Center, Houston, TX,', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085167557', 'display_name': 'Ran Reshef', 'orcid': 'https://orcid.org/0000-0003-2185-9546'}, 'institutions': [{'id': 'https://openalex.org/I78577930', 'display_name': 'Columbia University', 'ror': 'https://ror.org/00hj8s172', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I78577930']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ran Reshef', 'raw_affiliation_strings': ['9Columbia University, New York, NY,'], 'affiliations': [{'raw_affiliation_string': '9Columbia University, New York, NY,', 'institution_ids': ['https://openalex.org/I78577930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000370217', 'display_name': 'Arun Satelli', 'orcid': 'https://orcid.org/0000-0002-8733-5086'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Arun Satelli', 'raw_affiliation_strings': ['8Immatics US, Inc., Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '8Immatics US, Inc., Houston, TX,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030718446', 'display_name': 'Harpreet Singh', 'orcid': 'https://orcid.org/0000-0002-3367-7451'}, 'institutions': [{'id': 'https://openalex.org/I4210138096', 'display_name': 'Immatics Biotechnologies (Germany)', 'ror': 'https://ror.org/04qw0nt96', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210138096']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Harpreet Singh', 'raw_affiliation_strings': ['10Immatics N.V., Tuebingen, Germany,'], 'affiliations': [{'raw_affiliation_string': '10Immatics N.V., Tuebingen, Germany,', 'institution_ids': ['https://openalex.org/I4210138096']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044840107', 'display_name': 'Apostolia M. Tsimberidou', 'orcid': 'https://orcid.org/0000-0003-2713-233X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Apostolia-Maria Tsimberidou', 'raw_affiliation_strings': ['3The University of Texas, MD Anderson Cancer Center, Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '3The University of Texas, MD Anderson Cancer Center, Houston, TX,', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007396551', 'display_name': 'Steffen Walter', 'orcid': 'https://orcid.org/0000-0002-0249-2622'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Steffen Walter', 'raw_affiliation_strings': ['8Immatics US, Inc., Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '8Immatics US, Inc., Houston, TX,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085265624', 'display_name': 'Toni Weinschenk', 'orcid': 'https://orcid.org/0000-0001-8644-0290'}, 'institutions': [{'id': 'https://openalex.org/I4210138096', 'display_name': 'Immatics Biotechnologies (Germany)', 'ror': 'https://ror.org/04qw0nt96', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210138096']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Toni Weinschenk', 'raw_affiliation_strings': ['10Immatics N.V., Tuebingen, Germany,'], 'affiliations': [{'raw_affiliation_string': '10Immatics N.V., Tuebingen, Germany,', 'institution_ids': ['https://openalex.org/I4210138096']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036257821', 'display_name': 'Cedrik M. Britten', 'orcid': 'https://orcid.org/0000-0003-3424-8760'}, 'institutions': [{'id': 'https://openalex.org/I4210138096', 'display_name': 'Immatics Biotechnologies (Germany)', 'ror': 'https://ror.org/04qw0nt96', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210138096']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Cedrik M. Britten', 'raw_affiliation_strings': ['10Immatics N.V., Tuebingen, Germany,'], 'affiliations': [{'raw_affiliation_string': '10Immatics N.V., Tuebingen, Germany,', 'institution_ids': ['https://openalex.org/I4210138096']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5063337705', 'display_name': 'Jason J. Luke', 'orcid': 'https://orcid.org/0000-0002-1182-4908'}, 'institutions': [{'id': 'https://openalex.org/I170201317', 'display_name': 'University of Pittsburgh', 'ror': 'https://ror.org/01an3r305', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I170201317']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jason Luke', 'raw_affiliation_strings': ['11University of Pittsburgh, Pittsburgh, PA.'], 'affiliations': [{'raw_affiliation_string': '11University of Pittsburgh, Pittsburgh, PA.', 'institution_ids': ['https://openalex.org/I170201317']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 9, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.947, 'has_fulltext': False, 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.63932, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 92}, 'biblio': {'volume': '22', 'issue': '12_Supplement', 'first_page': 'PR018', 'last_page': 'PR018'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10580', 'display_name': 'Immunotherapy and Immune Responses', 'score': 0.9736, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9734, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/refractory', 'display_name': 'Refractory (planetary science)', 'score': 0.43056375}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.82027197}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5711269}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5135758}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.49605355}, {'id': 'https://openalex.org/C2776090121', 'wikidata': 'https://www.wikidata.org/wiki/Q193529', 'display_name': 'T cell', 'level': 3, 'score': 0.43945768}, {'id': 'https://openalex.org/C19317047', 'wikidata': 'https://www.wikidata.org/wiki/Q412037', 'display_name': 'T-cell receptor', 'level': 4, 'score': 0.43124148}, {'id': 'https://openalex.org/C142424586', 'wikidata': 'https://www.wikidata.org/wiki/Q7307572', 'display_name': 'Refractory (planetary science)', 'level': 2, 'score': 0.43056375}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.4238255}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.27507022}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.2711522}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.22379941}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C87355193', 'wikidata': 'https://www.wikidata.org/wiki/Q411', 'display_name': 'Astrobiology', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-23-pr018', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.76, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2168929838', 'https://openalex.org/W2140205174', 'https://openalex.org/W2092033815', 'https://openalex.org/W2064485034', 'https://openalex.org/W2060075608', 'https://openalex.org/W2040128205', 'https://openalex.org/W2037024992', 'https://openalex.org/W2026444950', 'https://openalex.org/W1971240700', 'https://openalex.org/W104003022'], 'abstract_inverted_index': {'Abstract': [0], 'T': [1, 37, 257, 295, 319, 425], 'cell': [2, 6, 38], 'receptor': [3], '(TCR)-based': [4], 'adoptive': [5], 'therapy': [7, 39], 'represents': [8], 'an': [9, 34, 52, 298, 323, 339, 393], 'innovative': [10, 490], 'and': [11, 49, 70, 76, 95, 97, 117, 143, 184, 227, 275, 286, 332, 351, 380, 382, 403, 436, 452, 576], 'promising': [12], 'treatment': [13, 433, 491], 'for': [14, 493], 'pts': [15, 103, 175, 247, 282, 311, 336, 497], 'with': [16, 46, 63, 139, 205, 262, 317, 322, 442, 498, 557], 'solid': [17, 87, 108, 495, 562], 'cancers': [18], 'who': [19], 'continue': [20], 'to': [21, 303, 327, 466], 'have': [22, 104, 118], 'a': [23, 42, 60, 64, 81, 206, 243, 252, 352, 410, 461, 476, 488], 'high': [24, 47, 82, 453, 477], 'unmet': [25], 'medical': [26], 'need.': [27], 'This': [28], 'ongoing': [29, 394], 'trial': [30], '(NCT03686124)': [31], 'evaluates': [32], 'IMA203,': [33], 'autologous': [35], 'TCR-engineered': [36], '(TCR-T)': [40], 'utilizing': [41], 'novel,': [43], 'pairing-enhanced': [44], 'TCR': [45], 'affinity': [48], 'specificity': [50], 'against': [51], 'HLA-A*02:01-presented': [53], 'peptide': [54], 'derived': [55], 'from': [56, 173], 'PRAME.': [57], 'PRAME': [58, 124, 454, 550], 'is': [59, 126, 150, 469], 'multi-cancer': [61], 'target': [62, 225], 'prevalence': [65, 83], 'of': [66, 115, 131, 208, 222, 224, 232, 245, 254, 281, 345, 355, 386, 412, 438, 479, 483, 560, 567], '80-100%': [67], 'in': [68, 84, 230, 235, 248, 283, 312, 389, 429, 555], 'cut.': [69, 371], 'uveal': [71, 373], 'melanoma,': [72, 372, 374], 'sarcoma': [73, 379], 'subtypes,': [74], 'uterine': [75], 'ovarian': [77, 376], 'cancer;': [78], 'it': [79], 'has': [80], 'many': [85, 494], 'other': [86], 'cancer': [88, 496], 'types,': [89, 368], 'such': [90], 'as': [91], 'lung,': [92], 'triple-negative': [93], 'breast': [94], 'head': [96, 381], 'neck': [98, 383], 'cancer,': [99, 109, 377], 'among': [100], 'others.': [101], 'Eligible': [102], 'recurrent': [105], 'and/or': [106], 'refractory': [107], 'are': [110], '≥18': [111], 'y,': [112], 'ECOG': [113], 'PS': [114], '0-1': [116], 'exhausted': [119], 'all': [120, 430], 'available': [121], 'SOC': [122], 'treatments.': [123], 'expression': [125, 455], 'assessed': [127], 'by': [128, 153], 'RT-qPCR': [129], 'analysis': [130], 'archived': [132], 'or': [133], 'fresh': [134], 'tumor': [135, 215, 367, 434, 484], 'tissue.': [136], 'After': [137], 'lymphodepletion': [138], 'Cy/Flu': [140], '(500': [141], 'mg/m2': [142, 145], '30': [144], 'IV': [146], 'x': [147, 161, 166], '4d),': [148], 'IMA203': [149, 256, 294, 318, 337, 424, 459, 547], 'infused': [151, 316], 'followed': [152], 'low-dose': [154], 'IL-2': [155], '(1': [156], 'mil': [157], 'IU': [158], 'SC': [159], 'daily': [160, 165], '5d,': [162], 'then': [163], 'twice': [164], '5d).': [167], 'Herein,': [168], 'we': [169], 'present': [170], 'preliminary': [171], 'results': [172], '38': [174], 'treated': [176, 289], 'across': [177, 365], 'the': [178, 192, 470, 568], 'phase': [179, 185, 236, 249, 284, 287, 313, 390], '1a': [180, 237, 285], 'dose': [181, 187], 'escalation': [182], '(N=27)': [183], '1b': [186, 250, 288, 314, 391], 'expansion': [188], 'cohort': [189], 'A': [190], 'at': [191, 290, 305, 348, 358, 396, 449], 'provisional': [193], 'RP2D': [194], '(N=11)': [195], '(data': [196], 'cut-off': [197], 'April': [198], '04,': [199], '2023).': [200], 'Pts': [201, 234], 'were': [202, 260, 315, 363, 427, 447], 'heavily': [203], 'pre-treated': [204], 'median': [207, 244, 253], '4': [209], 'prior': [210], 'systemic': [211], 'therapies.': [212], 'At': [213, 409], 'baseline,': [214], 'burden': [216], 'was': [217, 416, 440], '113': [218], 'mm': [219], '(median': [220], 'sum': [221], 'diameters': [223], 'lesions)': [226], 'LDH': [228], '&amp;gt;ULN': [229], '63%': [231], 'pts.': [233], '(dose': [238], 'level,': [239], 'DL,': [240], '1-4)': [241], 'received': [242], '0.41x109,': [246], '(DL4/5)': [251], '3.94x109': [255], 'cells.': [258], 'TEAEs': [259], 'manageable': [261, 462], 'most': [263], 'common': [264], 'events': [265], 'being': [266], 'expected': [267], 'cytopenias': [268], '(100%),': [269], 'CRS': [270], '(92%': [271], 'G1-2,': [272], '3%': [273], 'G3)': [274], 'ICANS': [276], '(13%': [277], 'G1-2).': [278], '61%': [279], '(11/18)': [280], 'DL4/5': [291], 'above': [292], '1x109': [293], 'cells': [296, 320, 426], 'showed': [297, 460], 'initial': [299, 340], 'objective': [300, 341, 443, 480], 'response': [301, 342, 395], 'according': [302], 'RECIST1.1': [304], 'week': [306, 349], '6': [307, 350, 399], 'post': [308, 407, 432], 'infusion.': [309, 408], '11': [310], 'manufactured': [321], 'improved': [324], 'process': [325], 'leading': [326], 'significantly': [328], 'increased': [329], 'TCR-T': [330, 472, 548], 'levels': [331], 'persistence.': [333], 'In': [334, 457], 'these': [335], 'achieved': [338], 'rate': [343, 478], '(ORR)': [344], '64%': [346], '(7/11)': [347], 'confirmed': [353], 'ORR': [354], '67%': [356], '(6/9)': [357], 'month': [359], '3.': [360], 'Objective': [361, 445], 'responses': [362, 446, 481], 'observed': [364, 448], 'multiple': [366], 'including': [369], 'PD1-refractory': [370], 'platinum-resistant': [375], 'synovial': [378], 'cancer.': [384], '5': [385], '7': [387], 'responders': [388], 'had': [392], '9': [397], '(N=2),': [398], '(N=1),': [400, 402], '3': [401], '1.5': [404], 'months': [405], '(N=1)': [406], 'mFU': [411], '8.5': [413], 'months,': [414], 'mDOR': [415], 'not': [417], 'reached': [418], '(min': [419], '1.3+,': [420], 'max': [421], '8.8+': [422], 'months).': [423], 'detectable': [428], 'evaluable': [431], 'tissues': [435], 'degree': [437], 'infiltration': [439], 'associated': [441], 'responses.': [444], 'low,': [450], 'medium': [451], 'levels.': [456], 'summary,': [458], 'tolerability': [463], 'profile': [464], 'and,': [465], 'our': [467], 'knowledge,': [468], 'first': [471], 'product': [473], 'candidate': [474], 'achieving': [475], 'independent': [482], 'type,': [485], 'thus': [486], 'providing': [487], 'potential': [489], 'option': [492], 'PRAME-positive': [499], 'tumors.': [500], 'Citation': [501], 'Format:': [502], 'Martin': [503], 'Wermke,': [504], 'Winfried': [505], 'Alsdorf,': [506], 'Dejka': [507], 'Araujo,': [508], 'Manik': [509], 'Chatterjee,': [510], 'Norbert': [511], 'Hilf,': [512], 'Tobias': [513], 'A.W.': [514], 'Holderried,': [515], 'Amir': [516], 'A.': [517], 'Jazaeri,': [518], 'Mamta': [519], 'Kalra,': [520], 'Andrea': [521], 'Mayer-Mokler,': [522], 'Regina': [523], 'Mendrzyk,': [524], 'Ali': [525], 'Mohamed,': [526], 'Sapna': [527], 'P.': [528], 'Patel,': [529], 'Ran': [530], 'Reshef,': [531], 'Arun': [532], 'Satelli,': [533], 'Harpreet': [534], 'Singh,': [535], 'Apostolia-Maria': [536], 'Tsimberidou,': [537], 'Steffen': [538], 'Walter,': [539], 'Toni': [540], 'Weinschenk,': [541], 'Cedrik': [542], 'M.': [543], 'Britten,': [544], 'Jason': [545], 'Luke.': [546], 'targeting': [549], 'demonstrates': [551], 'potent': [552], 'anti-tumor': [553], 'activity': [554], 'patients': [556], 'different': [558], 'types': [559], 'metastatic': [561], 'tumors': [563], '[abstract].': [564], 'In:': [565], 'Proceedings': [566], 'AACR-NCI-EORTC': [569], 'Virtual': [570], 'International': [571], 'Conference': [572], 'on': [573], 'Molecular': [574], 'Targets': [575], 'Cancer': [577, 588], 'Therapeutics;': [578], '2023': [579], 'Oct': [580], '11-15;': [581], 'Boston,': [582], 'MA.': [583], 'Philadelphia': [584], '(PA):': [585], 'AACR;': [586], 'Mol': [587], 'Ther': [589], '2023;22(12': [590], 'Suppl):Abstract': [591], 'nr': [592], 'PR018.': [593]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4389241704', 'counts_by_year': [{'year': 2024, 'cited_by_count': 5}], 'updated_date': '2024-12-26T07:12:13.102324', 'created_date': '2023-12-02'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
